Galibier Capital Management Ltd. lowered its stake in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 24.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 406,762 shares of the company's stock after selling 134,562 shares during the period. Nutrien makes up 6.3% of Galibier Capital Management Ltd.'s investment portfolio, making the stock its 7th biggest holding. Galibier Capital Management Ltd. owned about 0.08% of Nutrien worth $20,185,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. Steward Partners Investment Advisory LLC increased its position in shares of Nutrien by 11.2% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 4,736 shares of the company's stock worth $212,000 after acquiring an additional 477 shares in the last quarter. Assetmark Inc. increased its position in shares of Nutrien by 1,437.5% during the fourth quarter. Assetmark Inc. now owns 738 shares of the company's stock worth $33,000 after acquiring an additional 690 shares in the last quarter. Bank Julius Baer & Co. Ltd Zurich bought a new stake in shares of Nutrien during the fourth quarter worth about $127,000. PNC Financial Services Group Inc. increased its position in shares of Nutrien by 43.8% during the fourth quarter. PNC Financial Services Group Inc. now owns 16,536 shares of the company's stock worth $740,000 after acquiring an additional 5,034 shares in the last quarter. Finally, Fairway Wealth LLC bought a new stake in Nutrien in the 4th quarter worth about $27,000. Institutional investors and hedge funds own 63.10% of the company's stock.
Nutrien Stock Performance
Shares of NTR stock traded up $0.15 during trading on Friday, reaching $60.95. 2,660,635 shares of the company's stock traded hands, compared to its average volume of 2,189,876. Nutrien Ltd. has a 1 year low of $43.70 and a 1 year high of $65.08. The company has a current ratio of 1.22, a quick ratio of 0.59 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $29.69 billion, a P/E ratio of 56.96, a PEG ratio of 1.15 and a beta of 0.80. The firm's 50-day moving average is $59.41 and its 200 day moving average is $53.83.
Nutrien (NYSE:NTR - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.24). Nutrien had a return on equity of 6.08% and a net margin of 2.05%. The firm had revenue of $4.67 billion during the quarter, compared to analysts' expectations of $5.16 billion. During the same quarter in the prior year, the company earned $0.46 earnings per share. The business's revenue for the quarter was down 5.4% compared to the same quarter last year. Equities research analysts expect that Nutrien Ltd. will post 3.72 EPS for the current year.
Nutrien Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 18th. Shareholders of record on Monday, June 30th will be paid a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 3.58%. The ex-dividend date is Monday, June 30th. Nutrien's dividend payout ratio is presently 203.74%.
Analysts Set New Price Targets
NTR has been the subject of a number of recent analyst reports. Royal Bank Of Canada upped their price objective on shares of Nutrien from $60.00 to $65.00 and gave the stock an "outperform" rating in a research report on Monday, May 12th. Morgan Stanley upped their price objective on shares of Nutrien from $60.00 to $65.00 and gave the stock an "equal weight" rating in a research report on Thursday, June 26th. Jefferies Financial Group reaffirmed a "hold" rating and issued a $66.00 price objective (up from $63.00) on shares of Nutrien in a research report on Friday. Oppenheimer boosted their target price on shares of Nutrien from $58.00 to $63.00 and gave the company an "outperform" rating in a research note on Tuesday, May 13th. Finally, TD Securities boosted their target price on shares of Nutrien from $64.00 to $67.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Nutrien presently has a consensus rating of "Hold" and an average price target of $62.50.
Read Our Latest Stock Report on NTR
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Further Reading
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
